The Silicon Valley company, Profusa,1 in partnership with the U.S. Defense Advanced Research Projects Agency (DARPA),2 has created an injectable biosensor capable of detecting the presence of an infection in your body.3 In early August 2019, months before COVID-19 became a household word, DARPA granted Profusa additional funding “to develop an early identification system to detect disease … Continue reading Injectable Biochip for Sars-CoV-2 Detection Nears FDA Approval